RGTI · Rigetti Computing, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-22 | Johnson Ray O |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2025, and modified on March 9, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.405 to $21.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
84,944 |
| 2026-06-15 | Clifton Michael S. |
Director |
Sell↓
Filing footnotes — Warrants (right to buy) (Direct)
Fully vested and exercisable. |
Warrants (right to buy)
|
94,733 |
| 2026-06-12 | Clifton Michael S. |
Director |
Sell↓
Filing footnotes — Warrants (right to buy) (Direct)
The price reported in Column 4 is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $10.80 to $11.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Fully vested and exercisable. |
Warrants (right to buy)
|
4,361 |
| 2026-06-09 | Clifton Michael S. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents an annual grant of restricted stock units ("RSUs") for service as a director of the Issuer. The shares underlying the RSUs will vest in full on the earlier of (i) the date of the Issuer's 2027 annual meeting of the stockholders (or the date immediately prior to such annual meeting if the Reporting Person's service as a director ends at such annual meeting) or (ii) on June 9, 2027, each subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. |
Common Stock
|
9,208 |
| 2026-06-09 | Iannotti Thomas J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents an annual grant of restricted stock units ("RSUs") for service as a director of the Issuer. The shares underlying the RSUs will vest in full on the earlier of (i) the date of the Issuer's 2027 annual meeting of the stockholders (or the date immediately prior to such annual meeting if the Reporting Person's service as a director ends at such annual meeting) or (ii) on June 9, 2027, each subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. |
Common Stock
|
9,208 |
| 2026-06-09 | Fitzgerald Alissa |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents an annual grant of restricted stock units ("RSUs") for service as a director of the Issuer. The shares underlying the RSUs will vest in full on the earlier of (i) the date of the Issuer's 2027 annual meeting of the stockholders (or the date immediately prior to such annual meeting if the Reporting Person's service as a director ends at such annual meeting) or (ii) on June 9, 2027, each subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. |
Common Stock
|
9,208 |
| 2026-06-09 | Johnson Ray O |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents an annual grant of restricted stock units ("RSUs") for service as a director of the Issuer. The shares underlying the RSUs will vest in full on the earlier of (i) the date of the Issuer's 2027 annual meeting of the stockholders (or the date immediately prior to such annual meeting if the Reporting Person's service as a director ends at such annual meeting) or (ii) on June 9, 2027, each subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. |
Common Stock
|
9,208 |
| 2026-06-08 | Johnson Ray O |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2025, and modified on March 9, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.725 to $21.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
5,971 |
| 2026-06-08 | Johnson Ray O |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2025, and modified on March 9, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.725 to $21.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
116,217 |
| 2026-06-03 | Clifton Michael S. |
Director |
Sell↓
Filing footnotes — Warrants (right to buy) (Direct)
Fully vested and exercisable. |
Warrants (right to buy)
|
54,012 |
| 2026-06-02 | Clifton Michael S. |
Director |
Sell↓
Filing footnotes — Warrants (right to buy) (Direct)
Fully vested and exercisable. |
Warrants (right to buy)
|
3,144 |
| 2026-06-01 | Kulkarni Subodh K |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold by the Reporting Person in order to pay the exercise price of stock options and/or to cover certain taxes in connection with the exercise of stock options. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.08 to $24.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
61,000 |
| 2026-05-29 | Rivas David |
CHIEF TECHNOLOGY OFFICER |
Convert↑
|
Common Stock
|
33,053 |
| 2026-05-29 | Rivas David |
CHIEF TECHNOLOGY OFFICER |
Convert↑
|
Common Stock
|
393 |
| 2026-05-29 | Rivas David |
CHIEF TECHNOLOGY OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.7549 to $25.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
499,328 |
| 2026-05-29 | Rivas David |
CHIEF TECHNOLOGY OFFICER |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The stock option is fully vested and exercisable. |
Employee Stock Option (right to buy)
|
75,131 |
| 2026-05-29 | Rivas David |
CHIEF TECHNOLOGY OFFICER |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The stock option is fully vested and exercisable. |
Employee Stock Option (right to buy)
|
393 |
| 2026-05-29 | Rivas David |
CHIEF TECHNOLOGY OFFICER |
Convert↑
|
Common Stock
|
3,541 |
| 2026-05-29 | Rivas David |
CHIEF TECHNOLOGY OFFICER |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The stock option is fully vested and exercisable. |
Employee Stock Option (right to buy)
|
33,053 |
| 2026-05-29 | Rivas David |
CHIEF TECHNOLOGY OFFICER |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The stock option is fully vested and exercisable. |
Employee Stock Option (right to buy)
|
3,541 |
| 2026-05-29 | Rivas David |
CHIEF TECHNOLOGY OFFICER |
Convert↑
|
Common Stock
|
75,131 |
| 2026-05-28 | Kulkarni Subodh K |
Director |
Convert↑
|
Common Stock
|
111,111 |
| 2026-05-28 | Kulkarni Subodh K |
Director |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
One-thirty-sixth (1/36th) of this option vested and became exercisable on December 15, 2024, with the remainder vesting in equal monthly installments on the 15th day of each calendar month thereafter, subject to the Reporting Person's continuous service with the Issuer through each such vesting date. |
Employee Stock Option (right to buy)
|
33,490 |
| 2026-05-28 | Kulkarni Subodh K |
Director |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The stock option is fully vested and exercisable. |
Employee Stock Option (right to buy)
|
70,000 |
| 2026-05-28 | Kulkarni Subodh K |
Director |
Convert↑
|
Common Stock
|
33,490 |
| 2026-05-28 | Kulkarni Subodh K |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold by the Reporting Person in order to pay the exercise price of stock options and/or to cover certain taxes in connection with the exercise of stock options. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.20 to $26.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
43,190 |
| 2026-05-28 | Kulkarni Subodh K |
Director |
Convert↑
|
Common Stock
|
70,000 |
| 2026-05-28 | Kulkarni Subodh K |
Director |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
One-thirty-sixth (1/36th) of this option vested and became exercisable on December 22, 2023, with the remainder vesting in equal monthly installments on the 22nd day of each calendar month thereafter, subject to the Reporting Person's continuous service with the Issuer through each such vesting date. |
Employee Stock Option (right to buy)
|
111,111 |
| 2026-05-22 | Rivas David |
CHIEF TECHNOLOGY OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this row represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.76 to $23.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
18,729 |
| 2026-05-22 | Rivas David |
CHIEF TECHNOLOGY OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this row represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs"). |
Common Stock
|
30 |
| 2026-05-22 | Bertelsen Jeffrey A. |
CHIEF FINANCIAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this row represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of RSUs. |
Common Stock
|
13 |
| 2026-05-22 | Bertelsen Jeffrey A. |
CHIEF FINANCIAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this row represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of RSUs. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.76 to $23.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
3,669 |
| 2026-05-21 | Clifton Michael S. |
Director |
Sell↓
Filing footnotes — Warrants (right to buy) (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2025. Fully vested and exercisable. |
Warrants (right to buy)
|
50,000 |
| 2026-03-10 | Rivas David |
CHIEF TECHNOLOGY OFFICER |
Award↑
Filing footnotes — Common Stock (Direct)
Represents an award of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. One-fourth (1/4th) of the total number of RSUs (rounded down) will vest February 20, 2027 and thereafter one-sixteenth (1/16th) of the total number of RSUs (rounded down, except for the final scheduled vesting installment) will vest on the 20th day of the middle month of each quarter thereafter (i.e., February 20, May 20, August 20 and November 20), subject to the Reporting Person's continuous service with the Issuer through each such vesting date. |
Common Stock
|
80,000 |
| 2026-03-10 | Bertelsen Jeffrey A. |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
One-thirty-sixth (1/36th) of these stock options vest and become exercisable on the 10th day of each calendar month commencing in April 2026, subject to the Reporting Person's continuous service with the Issuer through each such vesting date. |
Employee Stock Option (Right to Buy)
|
180,000 |
| 2026-03-10 | Bertelsen Jeffrey A. |
CHIEF FINANCIAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this row represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of RSUs. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.35 to $17.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
4,270 |
| 2026-03-10 | Kulkarni Subodh K |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
One-thirty-sixth (1/36th) of these stock options vest and become exercisable on the 10th day of each calendar month commencing in April 2026, subject to the Reporting Person's continuous service with the Issuer through each such vesting date. |
Employee Stock Option (right to buy)
|
600,000 |
| 2026-03-10 | Rivas David |
CHIEF TECHNOLOGY OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this row represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.35 to $17.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
36,719 |
| 2026-02-09 | Clifton Michael S. |
Director |
Sell↓
Filing footnotes — Warrants (right to buy) (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.80 to $7.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Fully vested and exercisable. |
Warrants (right to buy)
|
50,000 |
| 2026-01-02 | Fitzgerald Alissa |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.02 to $22.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
59,316 |
| 2025-12-09 | Clifton Michael S. |
Director |
Sell↓
Filing footnotes — Warrants (right to buy) (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2025. The price reported in Column 8 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.60 to $16.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Fully vested and exercisable. |
Warrants (right to buy)
|
35,725 |
| 2025-12-09 | Clifton Michael S. |
Director |
Sell↓
Filing footnotes — Warrants (right to buy) (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2025. The price reported in Column 8 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.60 to $16.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Fully vested and exercisable. |
Warrants (right to buy)
|
64,275 |
| 2025-12-09 | Clifton Michael S. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.07 to $27.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
150,000 |
| 2025-11-20 | Bertelsen Jeffrey A. |
CHIEF FINANCIAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this row represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of RSUs. |
Common Stock
|
3,702 |
| 2025-11-20 | Rivas David |
CHIEF TECHNOLOGY OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this row represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of RSUs. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.01 to $26.3528, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
41,935 |
| 2025-10-17 | Sandford Helene Gail |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.61 to $45.215, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Common Stock
|
62,000 |
| 2025-09-19 | Sandford Helene Gail |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. |
Common Stock
|
1 |
| 2025-09-19 | Sandford Helene Gail |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.74 to $25.205, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Common Stock
|
17,634 |
| 2025-09-17 | Clifton Michael S. |
Director |
Sell↓
Filing footnotes — Warrants (Right to Buy) (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2025. Fully vested and exercisable. |
Warrants (Right to Buy)
|
100,000 |
| 2025-09-12 | Sandford Helene Gail |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.685 to $17.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) to (5) in this Form 4. |
Common Stock
|
7,773 |